Abstract:The protein-protein interactions (PPIs) in the biological systems are important to maintain a number of cellular processes. Several disorders including cancer may be developed due to dysfunction in the assembly of PPI networks. Hence, targeting intracellular PPIs can be considered as a crucial drug target for cancer therapy. Among the enormous and diverse group of cancer-enabling PPIs, the Hsp90-Cdc37 is prominent for cancer therapeutic development. The successful inhibition of Hsp90-Cdc37 PPI interface can be an important therapeutic option for cancer management. In the current study, a set of more than sixty thousand compounds belong to four databases were screened through a multi-steps molecular docking study in Glide against the Hsp90-Cdc37 interaction interface. The Glide-score and Prime-MM-GBSA based binding free energy of DCZ3112, standard Hsp90-Cdc37 inhibitor were found to be -6.96 and -40.46 kcal/mol, respectively. The above two parameters were used as cut-off score to reduce the chemical space from all successfully docked molecules. Furthermore, the in-silico pharmacokinetics parameters, common-feature pharmacophore analyses and the molecular binding interactions were used to wipe out the inactive molecules. Finally, four molecules were found to be important to modulate the Hsp90-Cdc37 interface. The potentiality of the final four molecules was checked through several drug-likeness characteristics. The molecular dynamics (MD) simulation study explained that all four molecules retained inside the interface of Hsp90-Cdc37. The binding free energy of each molecule obtained from the MD simulation trajectory was clearly explained the strong affection towards the Hsp90-Cdc37. Hence, the proposed molecule might be crucial for successful inhibition of the Hsp90-Cdc37 interface.Communicated by Ramaswamy H. Sarma.

In silico prediction, characterization, docking studies and molecular dynamics simulation of human p97 in complex with p37 cofactor

Molecular Mechanisms Driving and Regulating the AAA+ ATPase VCP/p97, an Important Therapeutic Target for Treating Cancer, Neurological and Infectious Diseases

Structural and Functional Analysis of Disease-Linked p97 ATPase Mutant Complexes

Mechanism of allosteric inhibition of human p97/VCP ATPase and its disease mutant by triazole inhibitors

Mechanistic Insight into Substrate Processing and Allosteric Inhibition of Human P97

Pharmacophore Modeling, Atom-Based 3D-QSAR and Molecular Docking Studies on N -Benzylpyrimidin-4-amine Derivatives As VCP/p97 Inhibitors

Characterizing ATP processing by the AAA+ protein p97 at the atomic level

Developing of Pharmacophore and Three-Dimensional Structure-Activity Relationship Models of VCP/p97 Ligands and Their Synthesis and Biological Evaluation

Structural insights of the p97/VCP AAA+ ATPase: How adapter interactions coordinate diverse cellular functionality

Evaluating P97 Inhibitor Analogues for Their Domain Selectivity and Potency Against the P97–p47 Complex

Exploring the Binding Mechanism Between Human Profilin (PFN1) and Polyproline-10 Through Binding Mode Screening

VCP/p97/Cdc48, A Linking of Protein Homeostasis and Cancer Therapy.

A targeted covalent inhibitor of p97 with proteome-wide selectivity

In silico identification of small molecule modulators for disruption of Hsp90-Cdc37 protein-protein interaction interface for cancer therapeutic application

Structure–Activity Relationship Study Reveals ML240 and ML241 as Potent and Selective Inhibitors of p97 ATPase

Cryo-EM structure of dodecamer human p97 in complex with NMS-873 reveals S765-G779 peptide plays critical role for D2 ring oligomerization

Synthesis and structure-activity relationships of N - (3 - (1H-imidazol-2-yl) phenyl) - 3-phenylpropionamide derivatives as a novel class of covalent inhibitors of p97/VCP ATPase

Valosin-Containing Protein (VCP)/p97 Oligomerization

Free Energy Profile and Kinetics of Coupled Folding and Binding of the Intrinsically Disordered Protein p53 with MDM2

Molecular chaperones cooperate with PIM1 protease in the degradation of misfolded proteins in mitochondria.

Seesaw Conformations of Npl4 in the Human p97 Complex and the Inhibitory Mechanism of a Disulfiram Derivative